Halitosis Treatment Market Reaches USD 17.7 Bn in 2026, Driven by Rising Oral Health Awareness and Increasing Prevalence of Bad Breath - Coherent Market Insights

Growing Adoption of Advanced Oral Care Products and Professional Treatments to Drive Halitosis Treatment Market to USD 35.6 Billion by 2033 at 10.5% CAGR – Coherent Market Insights

Halitosis Treatment Market – Driver 

• Rising Prevalence of Periodontal and Gum Diseases

The increasing prevalence of gingivitis, periodontitis, plaque accumulation, and other oral infections is driving demand for halitosis treatments, as these conditions are frequently associated with persistent bad breath. The WHO estimates that severe periodontal diseases affect more than one billion people globally. For instance, in March 2026, Haleon, a global consumer healthcare company reported that over 70% of adults in China experience some form of gum problem and announced a £65 million investment in a new oral-health manufacturing facility in Shanghai. (Source: Haleon, WHO)

• Increasing Product Innovation in Fresh-Breath Solutions

Manufacturers are introducing specialized toothpastes, therapeutic mouthwashes, sprays, lozenges, and other products that address odor-causing bacteria rather than temporarily masking bad breath. For instance, in May 2026, Church & Dwight Co., Inc., a U.S.-based consumer packaged goods company reported that TheraBreath had launched three new toothpaste variants offering long-lasting fresh breath, deep cleaning, whitening, and improved gum health. The products achieved an average consumer rating of 4.6 across multiple platforms. (Source: Church & Dwight Co., Inc.)

Halitosis Treatment Market – Opportunity

• Expansion of Integrated and Multifunctional Halitosis-Care Products

Companies have an opportunity to offer comprehensive treatment kits combining therapeutic toothpaste, antibacterial mouthwash, tongue cleaners, and gum-care products. The 2026 clinical guidelines for halitosis concluded that combining toothbrushing, mouth rinsing, and tongue cleaning is more effective than relying on a single intervention. For instance, in January 2026, Church & Dwight Co., Inc., consumer packaged goods company also highlighted the retail rollout of three TheraBreath toothpaste variants designed for long-lasting fresh breath, deep cleaning, whitening, and improved gum health, demonstrating demand for multifunctional oral-care solutions. (Source: Church & Dwight Co., Inc.)

• Development of Microbiome-Based and Probiotic Treatments

The growing understanding of the oral microbiome creates opportunities for manufacturers to develop probiotic lozenges, mouthwashes, toothpaste, and supplements that target odor-producing bacteria instead of merely masking bad breath. For instance, in February 2026, BioGaia, a Swedish healthcare company reported the continued international rollout of its Prodentis Fresh Breath probiotic lozenges. The company stated that initial U.S. feedback was positive and product sales had increased every month following launch. This indicates commercial potential for clinically supported, microbiome-friendly halitosis solutions.

Halitosis Treatment Market – Trends

• Shift Toward Alcohol-Free and Gentle Formulations

Alcohol-free, pH-balanced, botanical, and clean-label mouthwashes are gaining popularity among consumers seeking effective products without burning sensations or excessive dryness. In February 2026, TheraBreath launched its Eucalyptus Mint Oral Rinse at Target. The formulation is alcohol-free and excludes dyes, sulfates, and parabens while using botanical ingredients and a clinically supported approach to controlling odor-causing bacteria.

• Growing Adoption of Probiotic and Microbiome-Based Treatments

Halitosis treatment is shifting from temporarily masking odor toward balancing the oral microbiome and controlling odor-producing bacteria. In Q1 2026, BioGaia continued the rollout of its Prodentis Fresh Breath probiotic lozenges and introduced the product across Sweden, Germany, the U.K., and Finland. This expansion demonstrates increasing commercial interest in scientifically supported probiotic solutions for long-term breath management.

• Adoption of Objective and Technology-Based Diagnosis

Clinical management is increasingly incorporating portable sulphide monitors and gas-analysis technologies that measure volatile sulphur compounds responsible for oral malodor. The 2026 halitosis clinical-practice guidelines support more standardized and evidence-based diagnosis, while a June 2026 study evaluated the stability of breath samples for potential remote halitosis diagnosis. These developments could support personalized treatment selection and improved monitoring of treatment effectiveness.

• Rising Demand for Multifunctional Oral-Care Products

Consumers increasingly prefer products that provide fresh breath alongside gum protection, whitening, plaque control, and deep cleaning. In May 2026, Church & Dwight highlighted three TheraBreath toothpaste offerings addressing long-lasting freshness, deep cleaning, whitening, and gum health. The trend is also supported by 2026 clinical guidelines recommending combined toothbrushing, mouth rinsing, and tongue cleaning rather than reliance on a single treatment.

The Global Halitosis Treatment Market, by Type (Pathological and Non-pathological), by Treatment (Antacids, Antiseptics, Antiplaque, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 17.7 Billion in 2026, and is projected to exhibit a CAGR of 10.5% over the forecast period (2026 - 2033).

To know the latest trends and insights related to halitosis treatment market, click the link below:

https://www.coherentmarketinsights.com/market-insight/halitosis-treatment-market-2219

Key Takeaways of the Halitosis Treatment Market

• The global halitosis treatment market is expected to expand at a CAGR of 10.5% during the forecast period (2026 - 2033), owing to increasing occurrence of halitosis due various factors such as increasing consumption of tobacco, alcohol and sugary foods, and prevalence of various gastrointestinal diseases and infection of nose and throat. 
• Based on type, the pathological segment is expected to dominate the Halitosis Treatment Market with a 64.5% share in 2026. This leadership is attributed to the high incidence of clinically identifiable causes, including tongue biofilm, periodontal disease, oral infections, xerostomia, respiratory conditions, and gastrointestinal disorders, which require targeted and often ongoing treatment. For instance, clinical practice guidelines published in April 2026 reported that 80–90% of halitosis cases originate from intraoral conditions, including periodontal diseases, tongue coating, odontogenic diseases, mucosal disorders, and oral cancers.
• Based on treatment type, the antiseptics segment is expected to account for the largest market share of 38.2% in 2026, owing to the widespread use of antimicrobial mouth rinses for reducing odor-producing bacteria and volatile sulphur compounds. For instance, the 2026 clinical practice guidelines on halitosis stated that mouthwashes containing chlorhexidine, cetylpyridinium chloride, triclosan, or zinc are commonly used for halitosis management. The guidelines identified chlorhexidine as the most effective agent for reducing volatile sulphur compounds and described it as the gold-standard antimalodour mouthwash.
• Among region, the Asia Pacific is expected witness growth at highest rate during the forecast period, owing to increasing awareness among population about oral hygiene.
• Major players operating in the global halitosis treatment market include Abbott Laboratories, AstraZeneca Plc., Colgate-Palmolive Company, Dr. Harold Katz, Listerine, and Rowpar Pharmaceuticals

Key Developments

• In June 2026, University of Washington School of Dentistry researchers began testing oral microbiota transplants as a potential treatment for chronic halitosis. The first-of-its-kind clinical study transfers healthy oral bacteria from screened donors to patients after deep dental cleaning. Researchers aim to rebalance the oral microbiome so beneficial bacteria outcompete odor-producing microbes. Four transplants have been completed, with participants assessing breath improvement 90 days after treatment during scheduled follow-up evaluations. (Source: University of Washington)
• In June 2026, Listerine, an antiseptic mouthwash brand revealed the introduction of a nationwide range of mouthwash intensities, including a new alcohol-free Extra Mild option, responding to demand for gentler-tasting oral care without reduced efficacy. The portfolio also includes Mild and Intense variants, enabling personalized consumer choice. Kenvue said the products eliminate bad-breath, plaque, and gingivitis germs. The company is supporting the launch through its Swish Tour, retail activations, influencers, broader oral-care education initiatives, and public outreach.
• In February 2026, Procter & Gamble’s Crest, a global oral hygiene brand introduced Crest Clean Breath, a daily-use toothpaste formulated to neutralize odor-causing bacteria rather than temporarily masking bad breath. The company states that the toothpaste provides longer-lasting clean breath and 24-hour antibacterial protection when used twice daily. This is one of the most directly relevant 2026 launches for the halitosis treatment market.